Pro Share Advisors LLC Ardelyx, Inc. Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 45,325 shares of ARDX stock, worth $308,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,325

Previous 57,729 21.49%

Holding current value

$308,210

Previous $421,000 20.43%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.89 - $9.31 $73,059 - $115,481	-12,404 Reduced 21.49%	45,325 $335,000
Q1 2024 May 08, 2024	BUY	$6.05 - $9.74 $28,646 - $46,118	4,735 Added 8.93%	57,729 $421,000
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $36,459 - $73,584	11,082 Added 26.44%	52,994 $328,000
Q3 2023 Nov 13, 2023	BUY	$3.3 - $4.83 $1,102 - $1,613	334 Added 0.8%	41,912 $171,000
Q2 2023 Aug 10, 2023	BUY	$3.23 - $4.95 $89,829 - $137,664	27,811 Added 202.01%	41,578 $140,000
Q1 2023 May 11, 2023	SELL	$2.68 - $4.79 $4,655 - $8,320	-1,737 Reduced 11.2%	13,767 $65,000
Q4 2022 Feb 02, 2023	BUY	$1.22 - $2.85 $18,914 - $44,186	15,504 New	15,504 $44,000
Q2 2022 Aug 01, 2022	SELL	$0.51 - $1.17 $9,239 - $21,196	-18,117 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.65 - $1.18 $1,944 - $3,529	-2,991 Reduced 14.17%	18,117 $19,000
Q4 2021 Feb 08, 2022	SELL	$0.86 - $1.7 $10,532 - $20,819	-12,247 Reduced 36.72%	21,108 $22,000
Q3 2021 Nov 12, 2021	SELL	$1.27 - $8.17 $8,039 - $51,716	-6,330 Reduced 15.95%	33,355 $44,000
Q2 2021 Aug 13, 2021	BUY	$6.55 - $8.98 $48,574 - $66,595	7,416 Added 22.98%	39,685 $301,000
Q1 2021 May 14, 2021	BUY	$6.1 - $7.69 $11,840 - $14,926	1,941 Added 6.4%	32,269 $214,000
Q4 2020 Feb 09, 2021	BUY	$5.05 - $7.1 $35,375 - $49,735	7,005 Added 30.03%	30,328 $196,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $4,383 - $5,911	-835 Reduced 3.46%	23,323 $122,000
Q2 2020 Aug 03, 2020	BUY	$5.37 - $8.11 $44,452 - $67,134	8,278 Added 52.13%	24,158 $167,000
Q1 2020 May 15, 2020	SELL	$4.35 - $8.79 $17,904 - $36,179	-4,116 Reduced 20.58%	15,880 $90,000
Q4 2019 Feb 12, 2020	BUY	$4.23 - $8.29 $84,583 - $165,766	19,996 New	19,996 $150,000
Q4 2018 Feb 14, 2019	SELL	$1.66 - $4.16 $50,887 - $127,524	-30,655 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.75 - $4.65 $3,671 - $4,552	979 Added 3.3%	30,655 $133,000
Q2 2018 Aug 13, 2018	BUY	$3.7 - $5.8 $12,683 - $19,882	3,428 Added 13.06%	29,676 $110,000
Q1 2018 May 14, 2018	SELL	$5.05 - $7.9 $21,826 - $34,143	-4,322 Reduced 14.14%	26,248 $133,000
Q4 2017 Feb 14, 2018	BUY	$4.85 - $7.8 $7,536 - $12,121	1,554 Added 5.36%	30,570 $202,000
Q3 2017 Nov 13, 2017	BUY	$4.35 - $5.7 $7,577 - $9,929	1,742 Added 6.39%	29,016 $162,000
Q2 2017 Aug 11, 2017	BUY	N/A	27,274	27,274 $139,000

Others Institutions Holding ARDX

# of Institutions

208

Shares Held

144M

Call Options Held

1.01M

Put Options Held

1.43M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $1.05B
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Ardelyx, Inc. Transaction History